Sagent Pharmaceuticals launches oxaliplatin
SCHAUMBURG, Ill. — Drug maker Sagent Pharmaceuticals has launched a generic chemotherapy drug, the company said Thursday.
Sagent announced the launch of oxaliplatin, a generic version of Sanofi's Eloxatin.
Various versions of the drug had sales of about $1.7 billion during the 12-month period ended in June, according to IMS Health.
Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.